Calcitriol Prevents Cardiovascular Repercussions in Puromycin Aminonucleoside-Induced Nephrotic Syndrome

Table 2

Characterization of cardiac morphometry in control (Ct-V and Ct-D) and nephrotic (PAN-V and PAN-D) rats, after 21 days of calcitriol (D) or vehicle (V) treatments.

	Day 21
	Ct-V	Ct-D	PAN-V	PAN-D
Heart weight (mg)	923.3 ± 5.0	940.3 ± 27.2		933.8 ± 18.8
Heart weight/tibial length (mg/mm)	245.3 ± 4.8	249.9 ± 9.7		262.9 ± 6.2
LV weight/tibial length (mg/mm)	173.6 ± 7.0	178.8 ± 7.0		196.2 ± 3.2
RV weight/tibial length (mg/mm)	37.1 ± 1.7	40.2 ± 1.5	34.9 ± 1.5	31.6 ± 1.6

Values are means ± SE; to 4 experiments per group; LV, left ventricle; RV, right ventricle; , significantly different from corresponding values in Ct-V group.